GlassScriptPhysician profile
Nishad Nadkarni
NPI 1407245301
$2,938.84
in general payments reported to CMS, 2019-2025
8 companies · $58.36 in 2025
The $58.36 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.39 · 2020: $386 · 2021: $311 · 2022: $212 · 2023: $1,914 · 2024: $42.46 · 2025: $58.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,154 · Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,153.79 |
| Food and Beverage | $861.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,736.61 | 2023 | Indigo System, Penumbra System |
| Inari Medical, INC. | $587.81 | 2020-2022 | |
| Terumo Medical Corporation | $295.35 | 2020-2023 | Azur Cx Detachable, Navicross |
| Bard Peripheral Vascular, INC. | $231.44 | 2022-2025 | Set Aspirex S 10f 110cm, Covera, Trek |
| Pharmacyclics LLC, An Abbvie Company | $29.96 | 2022 | |
| Argon Medical Devices, INC. | $29.60 | 2023 | Biopince, Cleaner |
| Pfizer INC. | $14.39 | 2019 | |
| Siemens Medical Solutions USA, INC. | $13.68 | 2023 | Artis Icono Biplane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nishad Nadkarni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.